Lymphocyte activation gene-3 may synergize with other immune checkpoints, and the combination of anti-LAG-3 and anti-PD-1 resulted in more potent inhibition of murine tumor growth than single treatments (54). This evidence concerns the gene LAG3 and neoplasm.